Pascal and Francis Bibliographic Databases

Help

Search results

Your search

kw.\*:("Combrétastatine dérivé")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 87

  • Page / 4
Export

Selection :

  • and

Targeted Treatment of Choroidal Neovascularization Using Integrin-Mediated Sterically Stabilized Liposomes Loaded With Combretastatin A4LI MA; LIU, Yu-Ling; MA, Zhi-Zhong et al.Journal of ocular pharmacology and therapeutics. 2009, Vol 25, Num 3, pp 195-200, issn 1080-7683, 6 p.Article

Novel cyanocombretastatins as potent tubulin polymerisation inhibitorsJALILY, Pouria H; HADFIELD, John A; HIRST, Nicholas et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 21, pp 6731-6734, issn 0960-894X, 4 p.Article

Identification of the Human UDP-Glucuronosyltransferases Involved in the Glucuronidation of Combretastatin A-4APRILE, Silvio; DEL GROSSO, Erika; GROSA, Giorgio et al.Drug metabolism and disposition. 2010, Vol 38, Num 7, pp 1141-1146, issn 0090-9556, 6 p.Article

Synthesis, biological evaluation and molecular modeling of 1,2,3-triazole analogs of combretastatin A-1AKSELSEN, Øyvind W; ODLO, Kristin; CHENG, Jing-Jy et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 1, pp 234-242, issn 0968-0896, 9 p.Article

In Vitro Metabolism Study of Combretastatin A-4 in Rat and Human Liver MicrosomesAPRILE, Silvio; DEL GROSSO, Erika; CESARE TRON, Gian et al.Drug metabolism and disposition. 2007, Vol 35, Num 12, pp 2252-2261, issn 0090-9556, 10 p.Article

A validated HPLC method with fluorescence detection for the glucuronides of Combretastatin A1 in human plasma, and studies on their cis―trans isomerisationSTRATFORD, Michael R. L; FOLKES, Lisa K.Journal of pharmaceutical and biomedical analysis. 2012, Vol 62, pp 114-118, issn 0731-7085, 5 p.Article

Influence of the skeleton on the cytotoxicity of flavonoidsLEWIN, Guy; AUBERT, Genevieve; THORET, Sylviane et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 3, pp 1231-1239, issn 0968-0896, 9 p.Article

Combretastatin A-4 Phosphate Affects Tumor Vessel Volume and Size Distribution as Assessed Using MRI-Based Vessel Size ImagingNIELSEN, Thomas; BENTZEN, Lise; PEDERSEN, Michael et al.Clinical cancer research (Print). 2012, Vol 18, Num 23, pp 6469-6477, issn 1078-0432, 9 p.Article

Synthesis and biological evaluation of novel heterocyclic derivatives of combretastatin A-4BINH NGUYEN, Thi Thanh; LOMBERGET, Thierry; BARRET, Roland et al.Bioorganic & medicinal chemistry letters (Print). 2012, Vol 22, Num 23, pp 7227-7231, issn 0960-894X, 5 p.Article

Synthesis of Antimitotic Polyalkoxyphenyl Derivatives of Combretastatin Using Plant AllylpolyalkoxybenzenesSEMENOV, Victor V; KISELYOV, Alex S; KARMANOVA, Irina B et al.Journal of natural products (Print). 2010, Vol 73, Num 11, pp 1796-1802, issn 0163-3864, 7 p.Article

Nitric Oxide Synthase Inhibition Enhances the Tumor Vascular-Damaging Effects of Combretastatin A-4 3-O-Phosphate at Clinically Relevant DosesTOZER, Gillian M; PRISE, Vivien E; LEWIS, Gemma et al.Clinical cancer research (Print). 2009, Vol 15, Num 11, pp 3781-3790, issn 1078-0432, 10 p.Article

Enhanced fluorescence detection of cis-combretastatins by post-column photolysisSTRATFORD, Michael R. L.Journal of chromatography. 2008, Vol 1181, Num 1-2, pp 162-165, issn 0021-9673, 4 p.Article

Plants as a source of anti-cancer agents : Perspectives of ethnopharmacologyCRAGG, Gordon M; NEWMAN, David J.Journal of ethnopharmacology. 2005, Vol 100, Num 1-2, pp 72-79, issn 0378-8741, 8 p.Article

Radiation-Guided Targeting of Combretastatin Encapsulated Immunoliposomes to Mammary TumorsPATTILLO, Christopher B; VENEGAS, Berenice; DONELSON, Fred J et al.Pharmaceutical research. 2009, Vol 26, Num 5, pp 1093-1100, issn 0724-8741, 8 p.Article

Phase I Trial of Combretastatin A4 Phosphate (CA4P) in Combination with Bevacizumab in Patients with Advanced CancerNATHAN, Paul; ZWEIFEL, Martin; TAYLOR, N. Jane et al.Clinical cancer research (Print). 2012, Vol 18, Num 12, pp 3428-3439, issn 1078-0432, 12 p.Article

Pharmaceutical design of antimitotic agents based on combretastatinsHSIEH, H. P; LIOU, J. P; MAHINDROO, N et al.Current pharmaceutical design. 2005, Vol 11, Num 13, pp 1655-1677, issn 1381-6128, 23 p.Article

Synergistic gold effects of anti-vascular 4,5-diarylimidazol-2-ylidene gold(I) carbene complexesMÜNZNER, Julienne; BIERSACK, Bernhard; KAPS, Leonard et al.International journal of clinical pharmacology and therapeutics. 2013, Vol 51, Num 1, pp 44-46, issn 0946-1965, 3 p.Conference Paper

Targeted Polymeric Micelle System for Delivery of Combretastatin A4 to Tumor Vasculature In VitroYIGUANG WANG; TINGYUAN YANG; XUN WANG et al.Pharmaceutical research. 2010, Vol 27, Num 9, pp 1861-1868, issn 0724-8741, 8 p.Article

A Novel Approach to Combretastatins : From trans-Epoxide to CA-4 and Its Dioxolane DerivativeLUPATTELLI, Paolo; D'AURIA, Maurizio; DI BLASIO, Nadia et al.European journal of organic chemistry (Print). 2009, Num 1, pp 141-145, issn 1434-193X, 5 p.Article

Development of Synthetic Methodology Suitable for the Radiosynthesis of Combretastatin A-1 (CA1) and Its Corresponding Prodrug CA1PSHIRALI, Anupama; SRIRAM, Madhavi; BROWN, Rodney C et al.Journal of natural products (Print). 2009, Vol 72, Num 3, pp 414-421, issn 0163-3864, 8 p.Article

New oxazole-bridged combretastatin A-4 analogues as potential vascular-disrupting agentsMAHAL, Katharina; BIERSACK, Bernhard; SCHOBERT, Rainer et al.International journal of clinical pharmacology and therapeutics. 2013, Vol 51, Num 1, pp 41-43, issn 0946-1965, 3 p.Conference Paper

Synthesis and biological evaluation of 2-substituted-4-(3',4',5'-trimethoxy-phenyl)-5-aryl thiazoles as anticancer agentsROMAGNOLI, Romeo; GIOVANNI BARALDI, Pier; BASSO, Giuseppe et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 24, pp 7083-7094, issn 0968-0896, 12 p.Article

Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agentsYANG HU; XIANG LU; KE CHEN et al.Bioorganic & medicinal chemistry. 2012, Vol 20, Num 2, pp 903-909, issn 0968-0896, 7 p.Article

The Combretastatin Derivative (Cderiv), a Vascular Disrupting Agent, Enables Polymeric Nanomicelles to Accumulate in MicrotumorsHORI, Katsuyoshi; NISHIHARA, Masamichi; SHIRAISHI, Kouichi et al.Journal of pharmaceutical sciences. 2010, Vol 99, Num 6, pp 2914-2925, issn 0022-3549, 12 p.Article

Fluorescence lifetime imaging of E-combretastatin uptake and distribution in live mammalian cellsBISBY, Roger H; BOTCHWAY, Stanley W; HADFIELD, John A et al.European journal of cancer (1990). 2012, Vol 48, Num 12, pp 1896-1903, issn 0959-8049, 8 p.Article

  • Page / 4